Panaxia becomes first in Europe to be approved to export cannabis solution
They have so far used their special approval status to set up export agreements in Germany, France, Cyprus and Australia – leading the company to grow larger in a time when many other companies have struggled.
The company is currently exploring options for exporting the products through the controlling owner’s plant in Malta, or alternatively from other countries, in order to prepare for the launch and first sales in Germany of these products during the second half of 2021, in parallel with applying for an export permit from the Health Ministry.
Dr. Dadi Segal, Founder and CEO of Panaxia, said in a statement that “We are excited to be the first and only company in Europe to receive a marketing permit for inhaled medical cannabis extracts.”
Source: 420 Intel – Europe